Home Page
Counties
Miami-Dade
Miami
CBT4CBT, LLC

CBT4CBT, LLC - Florida Company Profile

Is this your business?

Get access!

Company Details

Entity Name:	CBT4CBT, LLC
Jurisdiction:	FLORIDA
Filing Type:	Florida Limited Liability Co. CBT4CBT, LLC is structured as a Limited Liability Company (LLC), a common business structure that offers its members limited liability protection, separating their personal assets from the company's debts and obligations. In Florida, LLCs are governed by Title XXXVI, Chapter 605, Florida Revised Limited Liability Company Act
Status:	Active The business entity is active. This status indicates that the business is currently operating and compliant with state regulations, suggesting a lower risk profile for lenders and potentially better creditworthiness.
Date Filed:	23 Oct 2020 (5 years ago)
Last Event:	CONVERSION
Event Date Filed:	23 Oct 2020 (5 years ago)
Document Number:	L20000330192
FEI/EIN Number	06-1446233 Federal Employer Identification (FEI) Number assigned by the IRS.
Address:	66 WEST FLAGLER STREET, SUITE 900, MIAMI, FL, 33130, US
Mail Address:	66 WEST FLAGLER STREET, SUITE 900, MIAMI, FL, 33130, US
ZIP code:	33130
City:	Miami
County:	Miami-Dade
Place of Formation:	FLORIDA

Key Officers & Management

Name	Role	Address
Liss Rosalyn	Manager	66 WEST FLAGLER STREET, SUITE 900, MIAMI, FL, 33130
-	Agent	-

U.S. Small Business Administration Profile

The U.S. Small Business Administration (SBA) helps Americans start, grow, and build resilient businesses.

Note: SBA was created in 1953 as an independent agency of the federal government to aid, counsel, assist and protect the interests of small business concerns; preserve free competitive enterprise; and maintain and strengthen the overall economy of our nation. SBA reviews Congressional and testifies on behalf of small businesses. It assesses the impact of regulatory burden on small businesses.

Phone Number:

203-605-7612

E-mail Address:

cbt4cbt.llc@gmail.com

Fax Number:

203-283-4182

Contact Person:

ROSALYN LISS

Ownership and Self-Certifications:

Self-Certified Small Disadvantaged Business, Women-Owned Small Business, Woman Owned

User ID:

P0705694

Unique Entity ID

A UEI is a government-provided number, like a tax ID number, that’s used to identify businesses eligible for federal grants, awards and contracts.

Note: In April 2022, the federal government replaced its old identifier of choice, the Data Universal Numbering System (DUNS) number, with a government-issued UEI. Now all the federal government’s Integrated Award Environment systems use UEI numbers instead of DUNS numbers. So any entity doing business with the federal government must register for a UEI.

Unique Entity ID:

CKDVY4EXD6M9

CAGE Code:

473W4

UEI Expiration Date:

2025-09-18

Business Information

Activation Date:

2024-09-20

Initial Registration Date:

2005-10-31

Commercial and government entity program

The The Commercial And Government Entity Code (CAGE) is assigned by the Department of Defense's Defense Logistics Agency (DLA) and represents your company's physical address for GSA's mailings, payments, and administrative records.

Note: A CAGE Code enables a company to contract with the U.S. government, allowing bid on government contracts and to receive government payments. Also for business this means that it's a Verified business entity and Has a validated physical address.

CAGE number:

473W4

Status:

Active

Type:

Non-Manufacturer

CAGE Update Date:

2024-09-20

CAGE Expiration:

2029-09-20

SAM Expiration:

2025-09-18

Contact Information

POC:

ROSALYN LISS

Events

Event Type	Filed Date	Value	Description
CONVERSION	2020-10-23	-	CORPORATION WAS A CONVERSION RESULT. CONVERTING CORPORATION WAS. CONVERSION NUMBER 900000206609

Documents

Name	Date
ANNUAL REPORT	2025-01-29
ANNUAL REPORT	2024-01-25
ANNUAL REPORT	2023-01-18
ANNUAL REPORT	2022-01-21
ANNUAL REPORT	2021-01-25
Florida Limited Liability	2020-10-23

USAspending Awards / Financial Assistance

Date:

2021-08-04

Link:

View on USAspending

Awarding Agency Name:

Department of Health and Human Services

Transaction Description:

A METHOD TO INCREASE BUPRENORPHINE TREATMENT CAPACITY AND EFFECTIVENESS - THE GOAL OF THIS FAST-TRACK STTR PROPOSAL IS TO EXPAND BUPRENORPHINE MAINTENANCE THERAPY FOR OPIOID- DEPENDENT PATIENTS. OVER 2.3 MILLION PEOPLE IN THE US ARE ADDICTED TO OPIATES. PROVIDING EFFECTIVE AGONIST THERAPY (METHADONE OR BUPRENORPHINE) COUPLED WITH BEHAVIORAL COUNSELING GREATLY IMPROVES OUTCOMES, REDUCES MORBIDITY, AND REDUCES SOCIETAL COSTS. METHADONE MAINTENANCE TREATMENT HAS BEEN LIMITED DUE TO COMPLEX STATE AND FEDERAL REGULATIONS AND THE NEED FOR OF DAILY CLINIC VISITS. BUPRENORPHINE WAS DEVELOPED AS AN ALTERNATIVE THAT COULD BE SELF-ADMINISTERED UNDER THE SUPERVISION OF A SPECIALLY TRAINED AND LICENSED PRIMARY CARE PHYSICIAN. HOWEVER, DUE TO A LACK OF AFFORDABLE ALTERNATIVES, PATIENTS ARE USUALLY REFERRED TO METHADONE OR SIMILAR CLINICS FOR COUNSELING, WHICH BUPRENORPHINE PATIENTS TEND TO DISLIKE AND THEN TEND TO DROP OUT OF TREATMENT (BUPRENORPHINE ATTRITION RATES ARE 50 - 70% IN PRIMARY CARE SETTINGS). THEREFORE, A COST-EFFECTIVE METHOD FOR DELIVERING AN ACCESSIBLE AND EFFECTIVE FORM OF COUNSELING FOR OFFICE-BASED BUPRENORPHINE IS NEEDED. TO THIS END, WE PROPOSE TO DEVELOP A BUPRENORPHINE-SPECIFIC VERSION OF CBT4CBT (COMPUTER BASED TRAINING FOR COGNITIVE BEHAVIORAL THERAPY), A WEB-BASED VALIDATED BEHAVIORAL COUNSELING PROGRAM. IN PHASE I, OUR SPECIFIC AIM IS TO TEST THE FEASIBILITY OF USING CBT4CBT ADAPTED FOR USE IN BUPRENORPHINE CERTIFIED PRIMARY CARE SETTINGS (CBT4CBT-BUPRENORPHINE). WE WILL TAILOR CBT4CBT FOR BUPRENORPHINE TREATMENT AND THEN CONDUCT A SMALL RANDOMIZED FEASIBILITY COMPARING IT WITH STANDARD BUPRENORPHINE MAINTENANCE. IN ADDITION, WE WILL DEVELOP AND EVALUATE A PHYSICIAN TUTORIAL TO ACCOMPANY THE CBT4CBT-BUPRENORPHINE PROGRAM IN PRIMARY CARE SETTINGS. TEST OF FEASIBILITY: THE CBT4CBT-BUPRENORPHINE GROUP MUST DEMONSTRATE A CLINICALLY MEANINGFUL EFFECT ON INCREASED RETENTION AND REDUCTION OF ILLEGAL DRUG USE AND INCREASED RETENTION RELATIVE TO STANDARD BUPRENORPHINE MAINTENANCE (AT LEAST 50% AND 30% IMPROVED, RESPECTIVELY). IN ADDITION, BOTH CLINICIANS AND PATIENTS MUST FIND CBT4CBT-BUPRENORPHINE IS USABLE (AVERAGE SCORE OF AT LEAST 3.5 FOR BOTH GROUPS ON A LIKERT LIKE SCALE OF 1-4 WITH 4 INDICATING `WOULD DEFINITELY USE CBT4CBT-BUPRENORPHINE AGAIN”). IN PHASE II, OUR SPECIFIC AIM IS TO DETERMINE IF THE USE OF CBT4CBT-BUPRENORPHINE LEADS TO CLINICALLY SIGNIFICANT IMPROVED OUTCOMES AND INCREASED RETENTION FOR PATIENTS IN A LARGER SAMPLE OF INDIVIDUALS SEEKING BUPRENORPHINE TREATMENT IN A PRIMARY CARE SETTING. TO THIS END, WE WILL IMPROVE CBT4CBT-BUPRENORPHINE, AS INFORMED BY THE PHASE I RESULTS, AND CARRY OUT AN RCT THAT IS POWERED TO DETECT SIGNIFICANCE FOR REDUCED OPIOID USE AND INCREASED RETENTION IN A COST EFFECTIVE MANNER. SATISFACTION AND USABILITY WILL ALSO BE EVALUATED AS IN PHASE I.

Obligated Amount:

1555945.22

Face Value Of Loan:

0.00

Total Face Value Of Loan:

0.00

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 01 Jul 2025

Sources: Florida Department of State